Wei‐Juin Su
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
Papers in
-
- Tuberculosis Research and Epidemiology 40
- Epidemiology 29
- Mycobacterium research and diagnosis 15
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Pneumonia and Respiratory Infections 5
- Co-authors
- Yi‐Shin Huang (3 shared papers)Shou‐Dong Lee (3 shared papers)Full‐Young Chang (2 shared papers)Herng‐Der Chern (2 shared papers)Jia‐Yih Feng (31 shared papers)Sheng‐Wei Pan (31 shared papers)Shi-Chuan Chang (3 shared papers)Vincent Yi‐Fong Su (17 shared papers)
- Journals
- Medicine (4 papers)European Respiratory Journal (4 papers)CHEST Journal (4 papers)PLoS ONE (3 papers)Journal of Microbiology Immunology and Infection (3 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Wei‐Juin Su
94 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 123
- Pharmacology 695
- Infectious Diseases 932
- Epidemiology 643
- Oncology 309
- Hepatology 87
Countries citing papers authored by Wei‐Juin Su
This map shows the geographic impact of Wei‐Juin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Juin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Juin Su more than expected).
Fields of papers citing papers by Wei‐Juin Su
This network shows the impact of papers produced by Wei‐Juin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Juin Su. The network helps show where Wei‐Juin Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Juin Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 365 | |
| 2 | 2003 | 349 | |
| 3 | 2007 | 185 | |
| 4 | 2014 | 121 | |
| 5 | 2012 | 74 | |
| 6 | 2017 | 69 | |
| 7 | 2016 | 65 | |
| 8 | 2017 | 59 | |
| 9 | 2018 | 57 | |
| 10 | 2011 | 52 | |
| 11 | 2017 | 49 | |
| 12 | 2014 | 45 | |
| 13 | 2010 | 41 | |
| 14 | 1992 | 40 | |
| 15 | 2016 | 38 | |
| 16 | 2004 | 36 | |
| 17 | 2017 | 36 | |
| 18 | 2020 | 33 | |
| 19 | 2011 | 32 | |
| 20 | 2019 | 32 |
About Wei‐Juin Su
Wei‐Juin Su is a scholar working on Infectious Diseases, Epidemiology, Surgery, Immunology and Pulmonary and Respiratory Medicine, having authored 98 papers that have together received 2.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (40 papers), Mycobacterium research and diagnosis (15 papers), Infectious Diseases and Tuberculosis (11 papers), Diagnosis and treatment of tuberculosis (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Pneumonia and Respiratory Infections (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Pharmacology (695 citations), Infectious Diseases (932 citations), Epidemiology (643 citations), Oncology (309 citations) and Hepatology (87 citations). Wei‐Juin Su has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yi‐Shin Huang, Shou‐Dong Lee, Full‐Young Chang, Herng‐Der Chern, Jia‐Yih Feng, Sheng‐Wei Pan, Shi-Chuan Chang, Vincent Yi‐Fong Su, Chi‐Huei Chiang and Yuh‐Min Chen. Their work appears in journals such as Medicine, European Respiratory Journal, CHEST Journal, PLoS ONE and Journal of Microbiology Immunology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.